jump to content jump to footer

Potential of using structured data from clinical trials and routine for AI and radiomics research

Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they have expanded their usage of mint Lesion™ over the years, how it has changed their clinical studies, and his view on the potential of structured data for research.

Video Clinical Trials Standardized Reading Procedures Clinical Routine Therapy Response Assessment AI Radiomics Structured Reporting

Related Resources

Hospital staff using mint Lesion for interoperable workflows and data management in lung cancer screening
How mint Lesion supports hospitals and screening centers with interoperable infrastructure, AI integration, data management, and scalable workflows for lung cancer screening.
Lung Cancer Screening in Germany: How mint Lesion Supports Hospitals with Infrastructure, Integration, and Scalability
Screening as a Strategic Challenge With the launch of the national lung cancer screening program in 2026, hospitals and screening centers across…
Radiologist analyzing whole-body MRI scans of prostate cancer bone metastases using AI-assisted tumor load quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted tumor load quantification for bone metastases in prostate cancer with structured analysis, objective metrics, and longitudinal therapy assessment.
AI-Supported Tumor Load Quantification for Bone Metastasis in Prostate Cancer
To assess treatment response in patients with advanced prostate cancer, radiologists rely on advanced medical imaging. Conventional modalities, such…
Radiologists participating in a hands-on lung cancer screening workshop using structured reporting software mint Lesion at RÖKO 2026
Interactive hands-on workshop on lung cancer screening according to G-BA guidelines at RÖKO 2026, including structured reporting, double reading workflows, and consensus decision-making
Hands-On Workshop Lung Cancer Screening: From Initial Read to Consenus
From initial read to consensus – structured reporting in practice at RÖKO 2026